A new indicator for breast cancer relapse identified
Researchers at the IMIM (Institut de Recerca Hospital del Mar) have proven that the absence of the 14-3-3 protein sigma in breast cancer cells is directly associated with these cells' capacity to activate the signalling of ...
Cancer
Jun 19, 2012 |
not rated yet |
0
'Hitchhiking' viral therapy deals a double blow to cancer
Scientists have shown how a promising viral therapy that delivers a double blow to cancer can sneak up on tumours undetected by hitching a ride on blood cells.
Cancer
Jun 13, 2012 |
not rated yet |
0
|
Blood test provides 'snapshot' of tumor drug response
(Medical Xpress) -- Counting the number of tumour cells in blood samples taken before and after treatment for advanced neuroendocrine tumors could provide a ‘snapshot’ of how well patients are responding ...
Cancer
Jun 06, 2012 |
not rated yet |
0
|
Blood test could lead to improved diagnosis and treatment of breast cancer
Scientists have discovered that a simple blood test could lead to better diagnosis and treatment for early-stage breast cancer patients, according to an Article published Online First in The Lancet Oncology.
Cancer
Jun 05, 2012 |
not rated yet |
0
Cancer treatment discovery opens tumours to immune cells
(Medical Xpress) -- Scientists at the Western Australian Institute for Medical Research (WAIMR) have made exciting progress in their quest to help patients fight cancer using the body's own immune system.The ...
Cancer
May 28, 2012 |
3 / 5 (2) |
0
|
Elimination of two ribosome subunits activates cell cycle control
Alterations in the formation of ribosomes (the elements of the cell where proteins are made) cause the induction of p53 protein and cell cycle disruption. This process is crucial to understand fundamental biological processes ...
Genetics
May 22, 2012 |
not rated yet |
0
Researchers announce the first comprehensive genome studies of the evolution of 21 breast cancers
In two back-to-back reports published online on 17 May in Cell, researchers have sequenced the genomes of 21 breast cancers and analysed the mutations that emerged during the tumours' development. The individual results are de ...
Cancer
May 17, 2012 |
5 / 5 (2) |
0
|
Children's brain tumors more diverse than previously believed
Paediatric brain tumours preserve specific characteristics of the normal cells from which they originate – a previously unknown circumstance with ramifications for how tumour cells respond to treatment. This has been ...
Cancer
May 14, 2012 |
not rated yet |
0
Scientists aim to kill lung tumors
Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth ...
Cancer
May 04, 2012 |
5 / 5 (2) |
0
|
Combination of 2 drugs reverses liver tumors
The combination of two inhibitors of protein mTOR stops the growth of primary liver cancer and destroys tumour cells, according to a study by researchers of the Group of Metabolism and Cancer at Bellvitge Biomedical Research ...
Medications
May 02, 2012 |
not rated yet |
0
Researchers identify 115 proteins that will allow designing new generation anti-cancer drugs
Researchers from the Research Programme in Biomedical Informatics (GRIB) from the IMIM (Hospital del Mar Research Institute) and the Pompeu Fabra University (UPF) have identified 115 proteins in silico (via computer simulation) ...
Cancer
Apr 26, 2012 |
not rated yet |
0
RANK protein promotes the initiation, progression and metastasis of human breast cancer
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that overactivation of the RANK signalling pathway promotes the initiation, progression and metastasis of tumours in human breast epithelial ...
Cancer
Apr 24, 2012 |
not rated yet |
0
Possible new cancer treatment identified
New research findings show how it may be possible to render cancer tumours harmless without affecting the other cells and tissues in the body. The findings apply to cancers including breast, lung and bowel cancer. The study ...
Cancer
Apr 19, 2012 |
not rated yet |
0
|
Balancing trastuzumab's survival benefits and heart risks for women with breast cancer
Adding trastuzumab (trade name Herceptin) to the treatment offered to women who have HER2-positive breast cancer, significantly increases the chance of life being prolonged, and reduces the chance of tumours reappearing once ...
Cancer
Apr 17, 2012 |
not rated yet |
0
Fatty acids fight cancer spread
Tiny agents found in omega-3 could potentially be used to block the path of primary cancer tumours, preventing the advance to secondary stage cancers according to pharmacy researchers at the University of ...
Cancer
Apr 10, 2012 |
not rated yet |
0
